Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis

Background. Myostatin is a regulator of muscle size. To date, there have been no published studies focusing on the relation between myostin levels and myopenia in rheumatoid arthritis (RA). Objective. Evaluate the value of serum myostatin as a biomarker of cachexia and low skeletal muscle mass (LSMM...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiola Gonzalez-Ponce, Jorge Ivan Gamez-Nava, Eli Efrain Gomez-Ramirez, Melissa Ramirez-Villafaña, Heriberto Jacobo-Cuevas, Norma Alejandra Rodriguez-Jimenez, Eva Maria Olivas-Flores, Yussef Esparza-Guerrero, Alejandro Martelli-García, Aline Priscilla Santiago-Garcia, Cesar Arturo Nava-Valdivia, Alejandra Martinez-Hernandez, Sergio Antonio Gonzalez-Vazquez, Alfredo Celis, Carlos Enrique Cabrera-Pivaral, Sylvia Totsuka-Sutto, Ernesto German Cardona-Muñoz, Laura Gonzalez-Lopez
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/7258152
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554980039458816
author Fabiola Gonzalez-Ponce
Jorge Ivan Gamez-Nava
Eli Efrain Gomez-Ramirez
Melissa Ramirez-Villafaña
Heriberto Jacobo-Cuevas
Norma Alejandra Rodriguez-Jimenez
Eva Maria Olivas-Flores
Yussef Esparza-Guerrero
Alejandro Martelli-García
Aline Priscilla Santiago-Garcia
Cesar Arturo Nava-Valdivia
Alejandra Martinez-Hernandez
Sergio Antonio Gonzalez-Vazquez
Alfredo Celis
Carlos Enrique Cabrera-Pivaral
Sylvia Totsuka-Sutto
Ernesto German Cardona-Muñoz
Laura Gonzalez-Lopez
author_facet Fabiola Gonzalez-Ponce
Jorge Ivan Gamez-Nava
Eli Efrain Gomez-Ramirez
Melissa Ramirez-Villafaña
Heriberto Jacobo-Cuevas
Norma Alejandra Rodriguez-Jimenez
Eva Maria Olivas-Flores
Yussef Esparza-Guerrero
Alejandro Martelli-García
Aline Priscilla Santiago-Garcia
Cesar Arturo Nava-Valdivia
Alejandra Martinez-Hernandez
Sergio Antonio Gonzalez-Vazquez
Alfredo Celis
Carlos Enrique Cabrera-Pivaral
Sylvia Totsuka-Sutto
Ernesto German Cardona-Muñoz
Laura Gonzalez-Lopez
author_sort Fabiola Gonzalez-Ponce
collection DOAJ
description Background. Myostatin is a regulator of muscle size. To date, there have been no published studies focusing on the relation between myostin levels and myopenia in rheumatoid arthritis (RA). Objective. Evaluate the value of serum myostatin as a biomarker of cachexia and low skeletal muscle mass (LSMM) in RA patients, along with whether high serum myostatin is associated to these conditions after adjusting for potential confounders. Methods. This cross-sectional study included 161 female RA patients and 72 female controls. In the RA group, we assessed several potential risk factors for LSMM and rheumatoid cachexia. Dual-energy X-ray absorptiometry was used to quantify the skeletal muscle mass index (SMMI) (considering LSMM≤5.5 kg/m2) and the presence of rheumatoid cachexia (a fat-free mass index≤10 percentile and fat mass index≥25 percentile of the reference population). Serum myostatin concentrations were determined by ELISA. To identify a cut-off for high serum myostatin levels, we performed ROC curve analysis. Multivariable logistic regression analysis was used to identify the risk factors for LSMM and rheumatoid cachexia. The risk was expressed as odds ratios (ORs) and their 95% confidence intervals (95% CIs). Results. Compared to the controls, the RA group had a higher proportion of LSMM and exhibited high serum myostatin levels (p<0.001). ROC curve analysis showed that a myostatin level≥17 ng/mL was the most efficient cut-off for identifying rheumatoid cachexia (sensitivity: 53%, specificity: 71%) and LSMM (sensitivity: 43%, specificity: 77%). In the multivariable logistic regression, RA with high myostatin levels (≥17 ng/mL) was found to increase the risk of cachexia (OR=2.79, 95% CI: 1.24-6.29; p=0.01) and LSMM (OR=3.04, 95% CI: 1.17-7.89; p=0.02). Conclusions. High serum myostatin levels increase the risk of LSMM and rheumatoid cachexia. We propose that high myostatin levels are useful biomarkers for the identification of patients in risk of rheumatoid cachexia and myopenia.
format Article
id doaj-art-f4185e5c6c6649e1a904fbe46b521916
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-f4185e5c6c6649e1a904fbe46b5219162025-02-03T05:49:59ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7258152Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid ArthritisFabiola Gonzalez-Ponce0Jorge Ivan Gamez-Nava1Eli Efrain Gomez-Ramirez2Melissa Ramirez-Villafaña3Heriberto Jacobo-Cuevas4Norma Alejandra Rodriguez-Jimenez5Eva Maria Olivas-Flores6Yussef Esparza-Guerrero7Alejandro Martelli-García8Aline Priscilla Santiago-Garcia9Cesar Arturo Nava-Valdivia10Alejandra Martinez-Hernandez11Sergio Antonio Gonzalez-Vazquez12Alfredo Celis13Carlos Enrique Cabrera-Pivaral14Sylvia Totsuka-Sutto15Ernesto German Cardona-Muñoz16Laura Gonzalez-Lopez17Programa de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaDepartamento de Microbiologia y PatologíaPrograma de Doctorado en FarmacologíaPrograma de Doctorado en FarmacologíaDivisión de Disciplinas para el DesarrolloDivisión de Disciplinas para el DesarrolloInstituto de Terapeutica Experimental y ClínicaInstituto de Terapeutica Experimental y ClínicaPrograma de Doctorado en FarmacologíaBackground. Myostatin is a regulator of muscle size. To date, there have been no published studies focusing on the relation between myostin levels and myopenia in rheumatoid arthritis (RA). Objective. Evaluate the value of serum myostatin as a biomarker of cachexia and low skeletal muscle mass (LSMM) in RA patients, along with whether high serum myostatin is associated to these conditions after adjusting for potential confounders. Methods. This cross-sectional study included 161 female RA patients and 72 female controls. In the RA group, we assessed several potential risk factors for LSMM and rheumatoid cachexia. Dual-energy X-ray absorptiometry was used to quantify the skeletal muscle mass index (SMMI) (considering LSMM≤5.5 kg/m2) and the presence of rheumatoid cachexia (a fat-free mass index≤10 percentile and fat mass index≥25 percentile of the reference population). Serum myostatin concentrations were determined by ELISA. To identify a cut-off for high serum myostatin levels, we performed ROC curve analysis. Multivariable logistic regression analysis was used to identify the risk factors for LSMM and rheumatoid cachexia. The risk was expressed as odds ratios (ORs) and their 95% confidence intervals (95% CIs). Results. Compared to the controls, the RA group had a higher proportion of LSMM and exhibited high serum myostatin levels (p<0.001). ROC curve analysis showed that a myostatin level≥17 ng/mL was the most efficient cut-off for identifying rheumatoid cachexia (sensitivity: 53%, specificity: 71%) and LSMM (sensitivity: 43%, specificity: 77%). In the multivariable logistic regression, RA with high myostatin levels (≥17 ng/mL) was found to increase the risk of cachexia (OR=2.79, 95% CI: 1.24-6.29; p=0.01) and LSMM (OR=3.04, 95% CI: 1.17-7.89; p=0.02). Conclusions. High serum myostatin levels increase the risk of LSMM and rheumatoid cachexia. We propose that high myostatin levels are useful biomarkers for the identification of patients in risk of rheumatoid cachexia and myopenia.http://dx.doi.org/10.1155/2022/7258152
spellingShingle Fabiola Gonzalez-Ponce
Jorge Ivan Gamez-Nava
Eli Efrain Gomez-Ramirez
Melissa Ramirez-Villafaña
Heriberto Jacobo-Cuevas
Norma Alejandra Rodriguez-Jimenez
Eva Maria Olivas-Flores
Yussef Esparza-Guerrero
Alejandro Martelli-García
Aline Priscilla Santiago-Garcia
Cesar Arturo Nava-Valdivia
Alejandra Martinez-Hernandez
Sergio Antonio Gonzalez-Vazquez
Alfredo Celis
Carlos Enrique Cabrera-Pivaral
Sylvia Totsuka-Sutto
Ernesto German Cardona-Muñoz
Laura Gonzalez-Lopez
Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
Journal of Immunology Research
title Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
title_full Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
title_fullStr Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
title_full_unstemmed Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
title_short Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
title_sort myostatin levels and the risk of myopenia and rheumatoid cachexia in women with rheumatoid arthritis
url http://dx.doi.org/10.1155/2022/7258152
work_keys_str_mv AT fabiolagonzalezponce myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT jorgeivangameznava myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT eliefraingomezramirez myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT melissaramirezvillafana myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT heribertojacobocuevas myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT normaalejandrarodriguezjimenez myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT evamariaolivasflores myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT yussefesparzaguerrero myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT alejandromartelligarcia myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT alinepriscillasantiagogarcia myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT cesararturonavavaldivia myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT alejandramartinezhernandez myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT sergioantoniogonzalezvazquez myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT alfredocelis myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT carlosenriquecabrerapivaral myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT sylviatotsukasutto myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT ernestogermancardonamunoz myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis
AT lauragonzalezlopez myostatinlevelsandtheriskofmyopeniaandrheumatoidcachexiainwomenwithrheumatoidarthritis